Purpose of the development: In Ukraine, which suffered the Chernobyl disaster mexamine highly recommended to protect personnel working with the radioactivity of the Chernobyl and other nuclear power plants, radioactive burial grounds and shelters, mandatory sale of affordable and effective drug in clinics with radiation therapy and radiography. The estimated population in need Mexamine - a few hundred pounds a year, the CIS market can absorb not less than 1000 kg of the substance per year, world demand - tons.

Recommended application field: Препарат официально разрешен к применению в гражданских клиниках для защиты пациентов при радиотерапии рака и рентгенографии.

Technical characteristic: Mexamine synthesis technology is a complex chemical-technological scheme, which is located on an area of about 2,000 sq. M., Which includes more than 60 active positions (reactors, centrifuges, measuring tanks, collectors and others.), Passive position (delivery environments, fire fighting , warehouse, laboratory and others.).

Advantages over analogues: Radioprotective effect mexamine strength exceeds or is at all known analogues in the world. There is a "know-how".

The development stage readiness: tested in laboratory condition

Description of the development:
()
Applicants have the "know-how", which allow to bypass complex chemical synthesis step using cheap raw materials, and, thus, make the technology highly profitable and competitive product (cost 300 USD / kg). At the end of 2005. The 1st phase of the project (PDR) is executed completely, Phase 2 (TDR) - 20%. To create an advanced technology of mexamine productivity of 200 kg / year in order to develop the technological parameters and receiving output data. Phase 3 of the project allows the organization of industrial production capacity of 3000-5000 kg / year.

Possibility of transfer abroad:
Licence's sale

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua